Sarcoidosis is a chameleon disease of unknown etiology, characterized by the growth of
non-necrotizing and non-caseating granulomas and manifesting with clinical pictures that …

Sarcoidosis is a heterogeneous disease, which can affect virtually every body organ, even
though lungs and intra thoracic lymph nodes are almost universally affected. The presence …

Biotechnological monoclonal antibodies and receptor antagonists capable of targeting
specific inflammatory actors, such as cytokines, cytokines receptors, co-stimulatory …

Sarcoidosis is a systemic inflammatory disease of unknown etiology. The pathogenesis rests
on an aberrant T cell response to unidentified antigens in individuals predisposed by …

Simple Summary Granulomatosis is commonly observed in patients receiving immune
checkpoint inhibitors (ICIs) for melanoma and other cancers. Recognizing this reaction early …

Drug-induced comorbidities in patients with sarcoidosis : Current Opinion in Pulmonary
Medicine Drug-induced comorbidities in patients with sarcoidosis : Current Opinion in …

Sarcoidosis is a multisystem disease characterized by the development and accumulation of
granulomas, the hallmark of an inflammatory process induced by environmental and/or …

Muscle involvement in sarcoidosis is common by pathologic analysis, but symptomatic
disorders are less frequent. Sarcoidosis-related muscle pathology includes non-caseating …

Sarcoidosis is a granulomatous multiorgan disease, thought to result from exposure to yet
unidentified antigens in genetically susceptible individuals. The exaggerated inflammatory …

A paradigm shift in cancer treatment occurred with the advent of immune checkpoint
inhibitors (ICI). ICI therapy has improved tumor response and increased overall survival in …